Worm Breeder's Gazette 5(2): 52

These abstracts should not be cited in bibliographies. Material contained herein should be treated as personal communication and should be cited as such only with the consent of the author.

Developmental Genetic Approach to Tumor Promotion in Chemical Carcinogenesis

J. Miwa, Y. Tabuse, K. Nishiwaki, M. Furusawa

Chemical carcinogenesis is thought to proceed in two stages: 
initiation and promotion.  Tumor promoters are agents that, although 
not themselves carcinogenic, induce tumors in animals previously 
exposed to a carcinogen (initiator).  Phorbol esters are the most 
potent known tumor promoters.  We have been studying how phorbol 
esters act as tumor promoters, taking advantage of C.  elegans, a 
favorable system for genetic and developmental studies.
The animal was treated with the tumor promoting phorbol esters TPA (
12-0-tetradecanoyl-phorbol-13-acetate) and PDD (phorbol 12,13-
didecanoate).  Both TPA and PDD at concentrations as low as 10-7M 
arrested growth when young animals were treated, reduced brood size 
when adults were treated, and caused uncoordinated movement in treated 
animals of any developmental stage.  Conversely, the nonpromoting 
derivatives phorbol and 4alpha-PDD (4alpha-phorbol 12,13-didecanoate) 
used as controls showed no effects on the animal.  The same pattern of 
structure-activity relationship has been observed in many biological 
and biochemical studies (cf.  Delcos et al.  1980).  The low 
concentrations of the compounds required to produce the effects and 
the characteristic structure-activity relationship observed suggest 
that the effects are specific and can be subjected to rigorous genetic 
and developmental analysis.
We have isolated many mutants resistent to tumor promoters.  The 
genetic characterization of mutants resistent to TPA suggests that no 
more than a few genes are involved in TPA action on the animal.  Also, 
all of the TPA resistent mutants so far tested are resistent to PDD 
and at least one of the tumor promoters that are not phorbol 
derivatives.  The approach we are taking we hope will lead to the 
eventual understanding of how tumor promoters act in chemical 
carcinogenesis.